Dare Bioscience, Inc. (DARE) vs Kiora Pharmaceuticals, Inc. (KPRX)
A side-by-side comparison of Dare Bioscience, Inc. and Kiora Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
KPRX
Kiora Pharmaceuticals, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 10:57 AM EDT
Total return — DARE vs KPRX
growth of $100 · dividends reinvested · last 10yDARE -99.3% (-39.4%/yr)KPRX -100.0% (-56.0%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
DARE KPRX
DARE vs KPRX: by the numbers
- •DARE is the larger company ($13M vs $11M market cap).
- •Both run net losses; KPRX's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | DARE | KPRX |
|---|---|---|
| P/S ratio | 9.20 | N/A |
| P/B ratio | N/A | 0.67 |
Profitability
| Metric | DARE | KPRX |
|---|---|---|
| Gross margin | -137.55% | 0.00% |
| Operating margin | -1315.51% | 0.00% |
| Net margin | -804.37% | 0.00% |
| ROE | N/A | -65.18% |
| ROIC | -203.50% | -59.42% |
Growth (annualized)
| Metric | DARE | KPRX |
|---|---|---|
| Total return CAGR (5Y) | -46.35% | -67.06% |
Frequently asked
- How have DARE and KPRX total returns compared?
- Over the past 10 years, DARE delivered -39.10% and KPRX delivered -55.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.